HEATHER DOUGLAS: Open Payments
NPI 1770164428 · LUMBERTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$861 in 42 payments from 12 companies in 2025. Trend: 2023 $439 · 2024 $480 · 2025 $861
Food & beverage: $861
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $200 |
| Amgen Inc. | 4 | $152 |
| Novo Nordisk Inc | 11 | $142 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $98 |
| Paratek Pharmaceuticals, Inc. | 5 | $97 |
| Insulet Corporation | 2 | $47 |
| Astellas Pharma US Inc | 2 | $36 |
| Ardelyx, Inc. | 1 | $22 |
| Corcept Therapeutics | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
Products named: Repatha, ZEPBOUND, Kerendia, MOUNJARO, NUZYRA, Omnipod, Ozempic, Veozah.
Industry payments across NC — which companies pay providers there.
